SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)				1 Months Ended	3 Months Ended		12 Months Ended
	Jan. 16, 2025	Jan. 14, 2025	Nov. 12, 2024	Jan. 31, 2026	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Jul. 31, 2023
Subsidiary, Sale of Stock [Line Items]
Number of common stock issued			$ 900,000	$ 75,000,000
Net proceeds after the deduction of offering costs					$ 367,000	$ 3,056,000
Intrinsic value for warrant shares					2,000
Restricted Stock Units (RSUs) [Member]
Subsidiary, Sale of Stock [Line Items]
Stock compensation-related expense					259,000	$ 76,000
Unamortized compensation					$ 554,000
2023 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock reserved for future issuance								1,650,000
Shares available for grant					877,395		877,395
Pre-Funded Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price		$ 0.001
Warrants exercised							2,500,000
Common Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price		$ 1.40
Security Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Purchase price of pre-funded unit	$ 3,500,000
Shares issued, price per share	$ 1.40
Net proceeds received from financing	$ 3,058,000
Security Purchase Agreement [Member] | Pre-Funded Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock, number of shares issued in transaction		2,500,000
Exercisable price per share		$ 0.001
Warrants to purchase of common stock		3,750,000
Security Purchase Agreement [Member] | Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Exercisable price per share		$ 1.399
ATM Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Purchase price of pre-funded unit				$ 4,500,000
Sale of stock rate				3.00%
Sale of stock					$ 385
Sale of stock, number of shares issued in transaction					589,845